The comparison of methods for the quantitative determination of coenzyme Q10


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Coenzyme Q10 is a biologically active compound that performs many important functions in the body: electron transfer in the mitochondrial cascade of adenosine triphosphate synthesis, antioxidant, preventing lipid peroxidation. Study Objective. The aim is to develop and compare methods for the quantitative determination of coenzyme Q10 in order to identify the most sensitive, simple and reproducible one. Materials and methods. Coenzyme Q10 was determined using high performance liquid chromatography with spectrophotomet-ric and mass spectrometric detectors. In developing the HPLC-MS / MS it was used the electrospray ionization (ESI) in positive mode. Detection was carried out in the mode of monitoring multiple reactions (MRM). Results. The study developed and validated two methods for the determination of coenzyme Q10 in plasma. It was shown that the most sensitive and reproducible technique was HPLC-MS / MS (the LLOQ constituted 0.10 μg / ml). One-step sample preparation involving proteins precipitation, used in the HPLC-MS / MS method was more convenient than in HPLC-UV one. The LLOQ of ubiquinone in the HPLC-UV method was 0.5 μg / ml. Using the HPLC-MS / MS technique, we analyzed the average concentration of endogenous CoQ10 in patients with cardiovascular pathologies administrating statins, p-blockers and calcium channel blockers, which constituted 0.39 μg / ml. Conclusion. It was concluded that the HPLC-UV method is unsuitable for routine practice use due to the high LLOQ (0.5 μg / ml) and its low sensitivity. While the of HPLC-MS / MS method was selective, sensitive, fast and convenient for introduction into routine practice.

Full Text

Restricted Access

About the authors

V. I Zozina

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: zozinavi@gmail.com
Post-graduate Student, Department of Clinical Pharmacology and Propaedeutics of Internal Diseases

E. S Melnikov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Ph.D. (Biol.), Assistant of the A.P. Arzamastsev Department of Pharmaceutical and Toxicological Chemistry

L. M Krasnykh

FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Ph.D. (Biol.), Head of Clinical Pharmacokinetics, Clinical Pharmacology Center

O. A Goroshko

FSBI «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Ph.D. (Pharm.), Senior Researcher, Clinical Pharmacokinetics, Clinical Pharmacology Center

V. G Kukes

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Academician of the RAS, Dr.Sc. (Med.), Professor, Department of Clinical Pharmacology and Propaedeutics of Internal Diseases

References

  1. Lunetta S., Roman M. Determination of coenzyme Q10 content in raw materials and dietary supplements by high-performance liquid chromatography-UV: collaborative study // J AOAC Int. 2008; 91(4):702-8.
  2. Orozco D., Skamarack J., Reins K., et al. Determination of ubidecarenone (coenzyme Q10, ubiquinol-10) in raw materials and dietary supplements by high-performance liquid chromatography with ultraviolet detection: singlelaboratory validation // J AOAC Int. 2007; 90(5):1227-36.
  3. Raitakari O.T., McCredie R.J., Witting P., et al. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults // Free Radic Biol Med. 2000; 28(7): 1100-5.
  4. Cobanoglu U., Demir H., Cebi A., et al. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment? // Asian Pac J Cancer Prev. 2011; 12(6):1399-403.
  5. Michalkiewicz S. Voltammetric determination of coenzyme Q10 in pharmaceutical dosage forms // Bioelectrochemistry. 2008; 73(1): 30-6.
  6. Battino M., Girotti S., et al. Free radical scavenging activity of coenzyme 0 measured by a chemiluminescent assay // Anal Chim Acta. 1991; 255:367-71.
  7. Karpinska J., Mikoluc B., Piotrowska-Jastrzebska J. Application of derivative spectrophotometry for determination of coenzyme Q10 in pharmaceuticals and plasma // J Pharm Biomed Anal. 1998; 17(8): 1345-50.
  8. Karpinska J., Mikoluc B., Motkowski R., et al. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma // J Pharm Biomed Anal. 2006; 42(2):232-6.
  9. Jiang P., Wu M., Zheng Y., et al. Analysis of coenzyme Q(10) in human plasma by column-switching liquid chromatography // J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 805(2):297-301.
  10. Hansen G., Christensen P., Tuchsen E., et al. Sensitive and selective analysis of coenzyme Q10 in human serum by negative APCI LC-MS // Analyst. 2004; 129(1):45-50.
  11. Иванов Р., Секарёва Г., Кравцова О., Кудлай Д., Лукьянов С., Тихонова И., Дёмин А., Максумова Л., Никитина И., Обухов А., Зайцев Д., Степанов А., Носырева М., Самсонов М. Правила проведения исследований биоаналоговых лекарственных средств (биоаналогов) // Фармакокинетика и фармакодинамика. 2014. № 1. С. 21-36

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies